Reconstruction Technology to Auxiliary Diagnosis and Guarantee Patient Privacy

Sponsor
Sun Yat-sen University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05058599
Collaborator
(none)
400
1
20.7
19.3

Study Details

Study Description

Brief Summary

Medical data that contain facial images are particularly sensitive as they retain important personal biometric identity, privacy protection. We developed a novel technology called "Digital Mask" (DM), based on real-time three-dimensional (3D) reconstruction and deep learning algorithm, to extract disease-relevant features but remove patient identifiable features from facial images of patients.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: DM

Study Design

Study Type:
Observational
Anticipated Enrollment :
400 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Using a Reconstruction Technology With Facial Pathological Features to Auxiliary Diagnosis and Guarantee Patient Privacy
Actual Study Start Date :
May 10, 2020
Anticipated Primary Completion Date :
Sep 20, 2021
Anticipated Study Completion Date :
Jan 30, 2022

Arms and Interventions

Arm Intervention/Treatment
facial videos dataset

facial videos collected from Zhongshan Ophthalmic Center of Sun Yat-sen University.

Diagnostic Test: DM
A new technology based on 3D reconstruction and deep learning algorithm to irreversibly erase the biometric attributes whilst retaining the clinical attributes needed for diagnosis and management

Outcome Measures

Primary Outcome Measures

  1. Diagnostic consistency [baseline]

    For each eye, both the diagnosis from the original videos and the diagnosis from the DM-reconstructed videos were recorded and compared. If the two diagnoses were consistent, it suggests that the reconstruction would be precise enough in clinical practice.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • The quality of facial images should be clinically acceptable.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Zhongshan Ophthalmic Center Guangzhou Guangdong China 510000

Sponsors and Collaborators

  • Sun Yat-sen University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Haotian Lin, Clinical Professor, Sun Yat-sen University
ClinicalTrials.gov Identifier:
NCT05058599
Other Study ID Numbers:
  • 2021KYPJ77
First Posted:
Sep 28, 2021
Last Update Posted:
Sep 28, 2021
Last Verified:
Sep 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Sep 28, 2021